ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 70 filers reported holding ANTARES PHARMA INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,616,000 | +10.7% | 2,701,137 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $9,591,000 | -4.3% | 2,686,553 | -2.4% | 0.00% | 0.0% |
| Q3 2021 | $10,022,000 | -9.4% | 2,753,540 | +8.5% | 0.00% | 0.0% |
| Q2 2021 | $11,060,000 | +12.7% | 2,536,666 | +6.2% | 0.00% | 0.0% |
| Q1 2021 | $9,814,000 | +102.6% | 2,387,984 | +96.7% | 0.00% | +50.0% |
| Q4 2020 | $4,843,000 | +58.0% | 1,213,867 | +6.9% | 0.00% | +100.0% |
| Q3 2020 | $3,065,000 | -3.3% | 1,135,100 | -1.6% | 0.00% | 0.0% |
| Q2 2020 | $3,171,000 | +18.8% | 1,153,065 | +1.9% | 0.00% | 0.0% |
| Q1 2020 | $2,670,000 | -49.0% | 1,131,449 | +1.6% | 0.00% | -50.0% |
| Q4 2019 | $5,232,000 | +109.9% | 1,113,268 | +49.3% | 0.00% | +100.0% |
| Q3 2019 | $2,493,000 | +10.7% | 745,412 | +8.9% | 0.00% | 0.0% |
| Q2 2019 | $2,252,000 | +24922.2% | 684,437 | +6425.9% | 0.00% | – |
| Q1 2016 | $9,000 | – | 10,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 1,820,524 | $4,697,000 | 3.00% |
| ARMISTICE CAPITAL, LLC | 12,050,000 | $31,089,000 | 2.03% |
| Broadfin Capital, LLC | 4,623,247 | $11,928,000 | 1.88% |
| Healthcare Value Capital, LLC | 100,000 | $258,000 | 0.73% |
| Healthcare Value Capital, LLC | 100,000 | $258,000 | 0.73% |
| MYCIO WEALTH PARTNERS, LLC | 2,433,500 | $6,278,000 | 0.65% |
| PERKINS CAPITAL MANAGEMENT INC | 317,500 | $819,000 | 0.59% |
| Brown Advisory Securities, LLC | 275,000 | $710,000 | 0.12% |
| FALCON POINT CAPITAL, LLC | 222,501 | $574,000 | 0.11% |
| Avenir Corp | 291,597 | $752,000 | 0.09% |